ENTERO — Entero Healthcare Solutions Income Statement
0.000.00%
- IN₹57.47bn
- IN₹60.15bn
- IN₹39.22bn
- 45
- 23
- 78
- 47
Annual income statement for Entero Healthcare Solutions, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13,496 | 17,797 | 25,221 | 33,002 | 39,223 |
Cost of Revenue | |||||
Gross Profit | 1,085 | 1,382 | 2,056 | 2,641 | 3,464 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,376 | 17,745 | 25,174 | 32,604 | 38,355 |
Operating Profit | 120 | 52.7 | 46.8 | 398 | 868 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38.7 | -108 | -198 | -36.9 | 356 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.9 | -154 | -294 | -111 | 398 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 9.44 | -155 | -299 | -116 | 391 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.44 | -155 | -299 | -116 | 391 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.217 | -3.57 | -6.88 | -2.66 | 10.8 |
Dividends per Share |